当前位置: 首页 > 期刊 > 《中国当代医药》 > 2017年第30期
编号:13101815
亮丙瑞林与戈舍瑞林对卵巢子宫内膜异位症术后复发及妊娠成功率的影响(4)
http://www.100md.com 2017年10月25日 《中国当代医药》 2017年第30期
     [11]Morelli M,Rocca ML,Venturella R,et al.Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis:a retrospective study[J].Gynecol Endocrinol,2013,29(4):305-308.

    [12]Khan KN.Kitajima M,Hiraki K,et al.Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis,adenomyosis and uterine myoma[J].Hum Reprod,2010,25:2878-2890.

    [13]Huang F,Wang H,Wu M,et al.Inhibitory effect of GnRHII and GnRH Ia on the stromal cell proliferation from endometriosis patients[J].J Cent South Univ Med,2011,36(6):554-558.

    [14]Ferrero S,Gillott DJ,Remorgida V,et al.GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis[J].J Reprod Med,2009,54(4):223-231.

    [15]Khan KN,Kitajima M,Hiraki K,et al.Changes in tissue inflammation,angiogenesis and apoptosis in endometriosis,adenomyosis and uterine myoma after GnRH agonist therapy[J].Hum Reprod,2010,25(3):642-653.

    [16]Weng H,Liu F,Hu S,et al.GnRH agonists induce endometrial epithelial cell apoptosis via GRP78 down-regulation[J].J Transl Med,2014,4(12):306.

    (收稿日期:2017-08-31 本文編辑:孟庆卿), http://www.100md.com(凡连云 万贵平)
上一页1 2 3 4